Gelbard, M., Goldstein, I., Hellstrom, W. J. G., McMahon, C. G., Smith, T., Tursi, J., . . . Carson, 3. (2013). Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies. The Journal of urology, 190(1), 199. https://doi.org/10.1016/j.juro.2013.01.087
Citácia podle Chicago (17th ed.)Gelbard, Martin, Irwin Goldstein, Wayne J G. Hellstrom, Chris G. McMahon, Ted Smith, James Tursi, Nigel Jones, Gregory J. Kaufman, a 3rd Carson. "Clinical Efficacy, Safety and Tolerability of Collagenase Clostridium Histolyticum for the Treatment of Peyronie Disease in 2 Large Double-blind, Randomized, Placebo Controlled Phase 3 Studies." The Journal of Urology 190, no. 1 (2013): 199. https://doi.org/10.1016/j.juro.2013.01.087.
Citácia podľa MLA (8th ed.)Gelbard, Martin, et al. "Clinical Efficacy, Safety and Tolerability of Collagenase Clostridium Histolyticum for the Treatment of Peyronie Disease in 2 Large Double-blind, Randomized, Placebo Controlled Phase 3 Studies." The Journal of Urology, vol. 190, no. 1, 2013, p. 199, https://doi.org/10.1016/j.juro.2013.01.087.